There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Apellis Pharmaceuticals (APLS – Research Report) ...

Special Needs Plans boosted a sluggish Medicare Advantage market during the annual enrollment period for 2025, a Modern ...

Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading ...

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the ...

Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which ...

After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

Health insurers involved in Medicaid on Thursday have recovered some of the losses incurred Wednesday after a Republican-led ...

Wall Street trading got off to a mixed start on Thursday following earnings from AI-darling Nvidia overnight and an update ...

Evolent Health faces volatility with missed targets and 2024 guidance cuts. Click here for a full investment analysis of EVH ...

A GOP budget plan that requires deep cuts to Medicaid spending battered shares of health insurers and hospitals that do big business in the government funded health program. Shares of Centene, t ...

Equity market performance in the fourth quarter was in many ways a microcosm of the past two years. Read more here.

Operating income fell for all but two major payers’ insurance divisions in the fourth quarter. And 2025 may be no better, ...